CombiGene
is a Sweden-based biotechnology company that researches and develops novel gene therapies for the treatment of dementia, and chronic diseases... Read moreCombiGene
is a Sweden-based biotechnology company that researches and develops novel gene therapies for the treatment of dementia, and chronic diseases... Read more
News
Oct 30, 2024
Cision
Press Release: CombiGene : BioStock: CombiGene implements cost savings
Aug 26, 2024
Cision
Press Release: CombiGene : BioStock: Continued focus on new licensing deals for CombiGene
Aug 23, 2024
Marketscreener
CombiGene: CombiGene AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
Jun 26, 2024
Cision
Press Release: CombiGene : BioStock: CombiGene positive to new license agreement for CG01
May 03, 2024
Cision
Press Release: CombiGene : BioStock: CombiGene's pain programme takes important steps forward
Mar 20, 2024
Cision
CombiGene: BioStock: CombiGene's CEO comments on the patent approvals in Australia and India
Feb 02, 2024
Cision
Press Release: CombiGene : BioStock: CombiGene comments on the discontinued CGT2 project
Jan 16, 2024
Cision
Press Release: CombiGene : CombiGene: "We continue to believe in the epilepsy project CG01"
Nov 15, 2023
Cision
Press Release: CombiGene : BioStock: CombiGene focuses on the pain project
Nov 01, 2023
Marketscreener
CombiGene: CombiGene Chooses Charles River Laboratories as A Partner for the Peptide-Based Pain Project COZY01